Schaeffer's Daily Market Blog Features Intel, Sprint Nextel, RF Micro Devices, Northfield Laboratories, and Vertex Pharmaceuticals.CINCINNATI -- Among the stocks featured in the February 22 edition of Schaeffer's Market Blog are Intel (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :INTC INTC Intel (NASDAQ symbol) INTC Intercept INTC Interrupt Controller ), Sprint Nextel Sprint Nextel Corporation (NYSE: S) is one of the largest telecommunications companies in the world. With 55 million subscribers, Sprint Nextel operates the third largest wireless telecommunications network in the United States (based on total wireless customers), behind (NYSE NYSE See: New York Stock Exchange :S), RF Micro Devices RF Micro Devices (NASDAQ: RFMD) is a manufacturer of integrated circuits, founded in Greensboro, NC, in 1991 by William J. Pratt, Powell T. Seymour and Jerry D. Neal.[1]. (NASDAQ:RFMD RFMD RF Micro Devices (NASDAQ) RFMD Rotary Fluid Management Device ), Northfield Laboratories (NASDAQ:NFLD NFLD Newfoundland ), and Vertex Pharmaceuticals (NASDAQ:VRTX An earlier real time operating system for embedded systems from Mentor Graphics, Wilsonville, OR (www.mentor.com). VRTX was the progenitor of the VxWorks OS from Wind River and was superseded by Nucleus OS. VRTX - Virtual Real-Time Executive. ). Schaeffer's Market Blog is just one of the many free market commentaries written everyday at www.SchaeffersResearch.com - the home of Bernie Schaeffer and Schaeffer's Investment Research. The Market Blog is written throughout every trading day by Schaeffer's financial analysts and traders. They are quick insights to the day's most notable market activity from an options perspective. For additional information about this report or to have it delivered to you free via email every day click on the following link. http://www.schaeffersresearch.com/redirect.aspx?CODE=PROB PROB Probable/Probably PROB Problem PROB People's Republic of Bangladesh 12M&PAGE=1. Schaeffer's Market Blog for Wednesday, February 22, 2006: Below are just a few of today's Market Blog entries. Click here to read all of today's Market Blog. http://www.schaeffersresearch.com/redirect.aspx?CODE=PROB1C&PAGE=1. Schaeffer's Gold Exclusive: For a limited time, you are viewing premium content from the Trading Floor Blog in Schaeffer's Gold. To get access to this outstanding blog every day, take your FREE TRIAL to Schaeffer's Gold at http://www.schaeffersresearch.com/ now. 9:51 AM Schaeffer's Radio Good morning. Just a reminder that some of our material is available in audio form at http://www.schaeffersresearch.com/commentary/podcasts/. I just posted today's edition of our Opening View observation, featuring Intel (NASDAQ:INTC), Sprint Nextel (NYSE:S) and OfficeMax (OMX OMX Office Max (stock symbol) ), plus all the regular news on market statistics, currencies, overseas trading, bonds, and commodities. 1:55 PM Put Options Heavy After Downgrade on RF Micro Devices RF Micro Devices (NASDAQ:RFMD) is looking stronger after a downgrade this morning that sent the shares lower by nearly four percent. The stock is hovering around the breakeven level at this point. Extreme pessimism may be the reason the shares were able to rebound. Options activity has included nearly 10 times as many put options as usual on the equity. 1:55 PM Northfield Laboratories Trades Lower in Reaction to Article A negative reaction to an article in this morning's issue of The Wall Street Journal has biotechnology firm Northfield Laboratories (NASDAQ:NFLD) trading more than seven percent lower. In the article titled "Amid Alarm Bells, Blood Substitute Keeps Pumping," the paper investigates past problems in clinical trials for the company's blood substitute PolyHeme. Several negative reactions occurred and some even caused the deaths of study participants. The piece notes that a new trial has begun and raises concerns about the protocol and safety of the study. NFLD responded and said the article contains several errors of fact and misinterprets the past clinical trial protocol A Clinical Trial Protocol is a document that describes the objective(s), design, methodology, statistical considerations, and organization of a clinical trial. The protocol usually also gives the background and reason the trial is being conducted, but these could be provided in and results. Further, it says the full data from that former study would have shown that PolyHeme could not be isolated as the cause of the observed serious adverse events. NFLD is trading at 11.38, its lowest level since April of last year. 4:21 PM Biotech Bounces Higher Biotech had a great day as the BTK Bruton's agammaglobulinemia tyrosine kinase (Btk) An enzyme vital for the maturation of B cells. Mentioned in: X-Linked Agammaglobulinemia gained over two percent to close at a new multi-year high, making it one of the top performers for the session. When it comes to biotechs I think that Vertex Pharmaceuticals (NASDAQ:VRTX) is the top name in the group. Technically, it is extremely strong and it has a good deal of skepticism as well, which, from our contrarian perspective this is encouraging. The above are just a few of today's Daily Market Blog entries. Click here to read all of today's Daily Market Blog. http://www.schaeffersresearch.com/redirect.aspx?CODE=PROB1C&PAGE=1. Take advantage of the timely Schaeffer commentaries by signing up for their free e-newsletters -- Opening View, Market Recap and Monday Morning Outlook. Click here to have the Schaeffer's commentaries delivered to you free via email every day. http://www.schaeffersresearch.com/redirect.aspx?CODE=PROB12M&PAGE=1. About Schaeffer's Investment Research (www.SchaeffersResearch.com) Schaeffer's Investment Research, founded by Bernie Schaeffer in 1981, is a financial information and trading resources company. It publishes Bernie Schaeffer's Option Advisor, the nation's leading options subscription newsletter. The firm's contrarian approach focuses on stocks with technical and fundamental trends that run counter to investor expectations. The firm's website, http://www.SchaeffersResearch.com , is recognized as one of the leading information sources for stock and options traders and was cited as the top options website by both Forbes and Barron's. Click here for more details about Schaeffer's trading methodology: http://www.SchaeffersResearch.com/method. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion